(Q42730006)
Statements
Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer (English)
Qingsong Liu
Jinhua Wang
Seong A Kang
Carson C Thoreen
Wooyoung Hur
15 February 2011